Kura Oncology, Inc. Annual Return On Equity in % from 2011 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Kura Oncology, Inc. quarterly/annual Return On Equity history and growth rate from 2011 to 2023.
  • Kura Oncology, Inc. Return On Equity for the quarter ending September 30, 2024 was -44.1 %, a 31.5% decline year-over-year.
  • Kura Oncology, Inc. annual Return On Equity for 2023 was -36.3 %, a 17.9% decline from 2022.
  • Kura Oncology, Inc. annual Return On Equity for 2022 was -30.8 %, a 28.8% decline from 2021.
  • Kura Oncology, Inc. annual Return On Equity for 2021 was -23.9 %, a 3.86% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -36.3 -5.52 -17.9% Jan 1, 2023 Dec 31, 2023
2022 -30.8 -6.89 -28.8% Jan 1, 2022 Dec 31, 2022
2021 -23.9 +0.96 +3.86% Jan 1, 2021 Dec 31, 2021
2020 -24.8 +4.92 +16.5% Jan 1, 2020 Dec 31, 2020
2019 -29.8 +12.5 +29.5% Jan 1, 2019 Dec 31, 2019
2018 -42.2 +11.7 +21.7% Jan 1, 2018 Dec 31, 2018
2017 -53.9 -12.6 -30.4% Jan 1, 2017 Dec 31, 2017
2016 -41.3 +1.32 +3.09% Jan 1, 2016 Dec 31, 2016
2015 -42.7 -45.9 -1434% Jan 1, 2015 Dec 31, 2015
2014 3.2 -22.4 -87.5% Jan 1, 2014 Dec 31, 2014
2013 25.6 +25.5 +55811% Jan 1, 2013 Dec 31, 2013
2012 0.05 -0.03 -37.8% Jan 1, 2012 Dec 31, 2012
2011 0.08 Jan 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.